The global Prothrombin Complex Concentrate (PCC) Drug market was valued at US$ 1467 million in 2025 and is anticipated to reach US$ 2900 million by 2032, at a CAGR of 10.4% from 2026 to 2032.

Prothrombin Complex Concentrate (PCC) Drug Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Prothrombin Complex Concentrate (PCC) Drug competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.

Prothrombin Complex Concentrate (PCC) drugs are plasma-derived, multi-factor coagulation products purified and viral-inactivated from human plasma. They primarily contain four vitamin K-dependent clotting factors—II, VII, IX, and X—and may also include natural anticoagulants such as protein C and protein S. PCC drugs are indicated for the treatment or prevention of bleeding caused by deficiencies in these factors, particularly in cases of warfarin overdose, severe liver dysfunction, or congenital coagulation disorders. Compared with traditional fresh frozen plasma, PCC offers faster onset of action, lower infusion volumes, and reduced infection risks, making it widely used in emergency anticoagulation reversal, surgical hemostasis, and critical bleeding management. With the growing number of patients on anticoagulant therapy and rising surgical and trauma care needs, PCC drugs are emerging as one of the fastest-growing segments in the global plasma-derived therapeutics market.In 2024, global Prothrombin Complex Concentrate (PCC) drugs production reached approximately 4.73 m units, with an average global market price of around US$ 280 perunit.The average gross profit margin of this product is 80%.

The expansion of the PCC drug market is driven by the growing clinical demand and the increasing reliance of healthcare systems on rapid hemostatic solutions. The rising prevalence of patients on anticoagulant therapy—especially those with atrial fibrillation, deep vein thrombosis, or valvular heart disease—has created significant demand for effective reversal agents. Furthermore, PCC’s rapid hemostatic effect in high-risk surgical procedures such as trauma, neurosurgery, and cardiothoracic operations has established it as a critical emergency medicine. New-generation four-factor PCCs are now recommended over three-factor formulations due to their superior efficacy in reversing warfarin effects. Meanwhile, technological advancements in viral inactivation, nanofiltration, and lyophilization have markedly enhanced product safety and stability, boosting market adoption worldwide.

Despite strong growth prospects, the PCC drug industry faces several structural challenges. The supply of human plasma remains constrained and highly regulated, with geographical concentration creating vulnerability to supply chain disruptions. Additionally, the risk of thrombosis associated with high-dose or repeated PCC administration imposes clinical caution. The long production cycle, complex cost structure, and high technical barriers also create significant entry challenges for new manufacturers. In some regions, the preference for lower-cost alternatives such as fresh frozen plasma or recombinant coagulation factors slows PCC adoption. Moreover, variations in national regulatory frameworks and blood product standards may further complicate global market expansion and compliance efforts.

The downstream demand for PCC drugs is becoming increasingly diversified. While traditionally used for warfarin reversal and management of severe bleeding, recent years have seen expanded indications, including bleeding associated with direct oral anticoagulants (DOACs), liver disease-related coagulopathy, perioperative anticoagulant reversal, and obstetric hemorrhage. National clinical guidelines have progressively positioned PCC as a first-line therapy for anticoagulation reversal, accelerating its adoption. In developed markets, PCC use has extended from intensive care units to emergency and general wards. In emerging economies, government healthcare programs and local plasma fractionation initiatives are driving broader market penetration. Looking ahead, standardized hospital inventory practices, emergency medicine training, and combined therapeutic protocols involving PCC and other hemostatic agents will further broaden its clinical scope.

The production of PCC drugs relies heavily on human plasma as the primary biological raw material. Its quality, supply stability, and regulatory compliance directly determine production capacity and product safety standards. Most plasma collection currently occurs in North America and Europe, where mature donor networks and traceable oversight systems are in place. With gradual policy liberalization, Asian countries such as China and India are emerging as new sources of plasma supply growth. In addition to plasma, the upstream chain involves critical components such as viral inactivation reagents, chromatographic media, and lyophilization equipment. While technological advances have improved yield and purity, the stringent ethical and regulatory constraints on plasma sourcing and international transport remain key bottlenecks in the global PCC supply chain.

This report delivers a comprehensive overview of the global Prothrombin Complex Concentrate (PCC) Drug market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Prothrombin Complex Concentrate (PCC) Drug. The Prothrombin Complex Concentrate (PCC) Drug market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Prothrombin Complex Concentrate (PCC) Drug market comprehensively. Regional market sizes by Type, by Application, by Usage Type, and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Prothrombin Complex Concentrate (PCC) Drug manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Prothrombin Complex Concentrate (PCC) Drug Market Report

Report Metric	Details
Report Name	Prothrombin Complex Concentrate (PCC) Drug Market
Accounted market size in 2025	US$ 1467 million
Forecasted market size in 2032	US$ 2900 million
CAGR	10.4%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	Beriplex Profilnine Octaplex Prothromplex Cofact Other
Segment by Usage Type	Lyophilized Powder Form Liquid Injection Form
Segment by Manufacturing Process	Plasma-Derived Recombinant Bioengineered
by Application	Hemophilia B Acquired Coagulation Factor Deficiency
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	CSL Behring, Grifols, Octapharma, Prothya Biosolutions, Takeda, RAAS, Hualan Bio, BOHUI, NUOYI BIO, SINOPHARM, Guangdong Weilun, Weiguang Bio, Kangbo Bio, Huarun Boya, Taibang Biologic
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Usage Type, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Prothrombin Complex Concentrate (PCC) Drug manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Prothrombin Complex Concentrate (PCC) Drug sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Prothrombin Complex Concentrate (PCC) Drug Market growing?

Ans: The Prothrombin Complex Concentrate (PCC) Drug Market witnessing a CAGR of 10.4% during the forecast period 2026-2032.

What is the Prothrombin Complex Concentrate (PCC) Drug Market size in 2032?

Ans: The Prothrombin Complex Concentrate (PCC) Drug Market size in 2032 will be US$ 2900 million.

Who are the main players in the Prothrombin Complex Concentrate (PCC) Drug Market report?

Ans: The main players in the Prothrombin Complex Concentrate (PCC) Drug Market are CSL Behring, Grifols, Octapharma, Prothya Biosolutions, Takeda, RAAS, Hualan Bio, BOHUI, NUOYI BIO, SINOPHARM, Guangdong Weilun, Weiguang Bio, Kangbo Bio, Huarun Boya, Taibang Biologic

What are the Application segmentation covered in the Prothrombin Complex Concentrate (PCC) Drug Market report?

Ans: The Applications covered in the Prothrombin Complex Concentrate (PCC) Drug Market report are Hemophilia B, Acquired Coagulation Factor Deficiency

What are the Type segmentation covered in the Prothrombin Complex Concentrate (PCC) Drug Market report?

Ans: The Types covered in the Prothrombin Complex Concentrate (PCC) Drug Market report are Lyophilized Powder Form, Liquid Injection Form

1 Prothrombin Complex Concentrate (PCC) Drug Market Overview

1.1 Product Definition

1.2 Prothrombin Complex Concentrate (PCC) Drug by Type

1.2.1 Global Prothrombin Complex Concentrate (PCC) Drug Market Value by Type: 2025 vs 2032

1.2.2 Beriplex

1.2.3 Profilnine

1.2.4 Octaplex

1.2.5 Prothromplex

1.2.6 Cofact

1.2.7 Other

1.3 Prothrombin Complex Concentrate (PCC) Drug by Usage Type

1.3.1 Global Prothrombin Complex Concentrate (PCC) Drug Market Value by Usage Type: 2025 vs 2032

1.3.2 Lyophilized Powder Form

1.3.3 Liquid Injection Form

1.4 Prothrombin Complex Concentrate (PCC) Drug by Manufacturing Process

1.4.1 Global Prothrombin Complex Concentrate (PCC) Drug Market Value by Manufacturing Process: 2025 vs 2032

1.4.2 Plasma-Derived

1.4.3 Recombinant Bioengineered

1.5 Prothrombin Complex Concentrate (PCC) Drug by Application

1.5.1 Global Prothrombin Complex Concentrate (PCC) Drug Market Value by Application: 2025 vs 2032

1.5.2 Hemophilia B

1.5.3 Acquired Coagulation Factor Deficiency

1.6 Global Prothrombin Complex Concentrate (PCC) Drug Market Size Estimates and Forecasts

1.6.1 Global Prothrombin Complex Concentrate (PCC) Drug Revenue 2021–2032

1.6.2 Global Prothrombin Complex Concentrate (PCC) Drug Sales 2021–2032

1.6.3 Global Prothrombin Complex Concentrate (PCC) Drug Market Average Price (2021–2032)

1.7 Assumptions and Limitations

2 Prothrombin Complex Concentrate (PCC) Drug Market Competition by Manufacturers

2.1 Global Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Manufacturers (2021–2026)

2.2 Global Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Manufacturers (2021–2026)

2.3 Global Prothrombin Complex Concentrate (PCC) Drug Average Price by Manufacturers (2021–2026)

2.4 Global Key Players of Prothrombin Complex Concentrate (PCC) Drug, Industry Ranking, 2023 vs 2024 vs 2025

2.5 Global Key Manufacturers of Prothrombin Complex Concentrate (PCC) Drug, Manufacturing Sites and Headquarters

2.6 Global Key Manufacturers of Prothrombin Complex Concentrate (PCC) Drug, Product Types and Applications

2.7 Global Key Manufacturers of Prothrombin Complex Concentrate (PCC) Drug, Date of Entry into the Industry

2.8 Global Prothrombin Complex Concentrate (PCC) Drug Market Competitive Situation and Trends

2.8.1 Global Prothrombin Complex Concentrate (PCC) Drug Market Concentration Rate

2.8.2 The Top 5 and Top 10 Global Prothrombin Complex Concentrate (PCC) Drug Players Market Share by Revenue

2.8.3 Global Prothrombin Complex Concentrate (PCC) Drug Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Prothrombin Complex Concentrate (PCC) Drug Market Scenario by Region

3.1 Global Prothrombin Complex Concentrate (PCC) Drug Market Size by Region: 2021 vs 2025 vs 2032

3.2 Global Prothrombin Complex Concentrate (PCC) Drug Sales by Region: 2021–2032

3.2.1 Global Prothrombin Complex Concentrate (PCC) Drug Sales by Region: 2021–2026

3.2.2 Global Prothrombin Complex Concentrate (PCC) Drug Sales by Region: 2027–2032

3.3 Global Prothrombin Complex Concentrate (PCC) Drug Revenue by Region: 2021–2032

3.3.1 Global Prothrombin Complex Concentrate (PCC) Drug Revenue by Region: 2021–2026

3.3.2 Global Prothrombin Complex Concentrate (PCC) Drug Revenue by Region: 2027–2032

3.4 North America Prothrombin Complex Concentrate (PCC) Drug Market Facts & Figures by Country

3.4.1 North America Prothrombin Complex Concentrate (PCC) Drug Market Size by Country: 2021 vs 2025 vs 2032

3.4.2 North America Prothrombin Complex Concentrate (PCC) Drug Sales by Country (2021–2032)

3.4.3 North America Prothrombin Complex Concentrate (PCC) Drug Revenue by Country (2021–2032)

3.4.4 United States

3.4.5 Canada

3.5 Europe Prothrombin Complex Concentrate (PCC) Drug Market Facts & Figures by Country

3.5.1 Europe Prothrombin Complex Concentrate (PCC) Drug Market Size by Country: 2021 vs 2025 vs 2032

3.5.2 Europe Prothrombin Complex Concentrate (PCC) Drug Sales by Country (2021–2032)

3.5.3 Europe Prothrombin Complex Concentrate (PCC) Drug Revenue by Country (2021–2032)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Prothrombin Complex Concentrate (PCC) Drug Market Facts & Figures by Region

3.6.1 Asia Pacific Prothrombin Complex Concentrate (PCC) Drug Market Size by Region: 2021 vs 2025 vs 2032

3.6.2 Asia Pacific Prothrombin Complex Concentrate (PCC) Drug Sales by Region (2021–2032)

3.6.3 Asia Pacific Prothrombin Complex Concentrate (PCC) Drug Revenue by Region (2021–2032)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Prothrombin Complex Concentrate (PCC) Drug Market Facts & Figures by Country

3.7.1 Latin America Prothrombin Complex Concentrate (PCC) Drug Market Size by Country: 2021 vs 2025 vs 2032

3.7.2 Latin America Prothrombin Complex Concentrate (PCC) Drug Sales by Country (2021–2032)

3.7.3 Latin America Prothrombin Complex Concentrate (PCC) Drug Revenue by Country (2021–2032)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Prothrombin Complex Concentrate (PCC) Drug Market Facts & Figures by Country

3.8.1 Middle East and Africa Prothrombin Complex Concentrate (PCC) Drug Market Size by Country: 2021 vs 2025 vs 2032

3.8.2 Middle East and Africa Prothrombin Complex Concentrate (PCC) Drug Sales by Country (2021–2032)

3.8.3 Middle East and Africa Prothrombin Complex Concentrate (PCC) Drug Revenue by Country (2021–2032)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Prothrombin Complex Concentrate (PCC) Drug Sales by Type (2021–2032)

4.1.1 Global Prothrombin Complex Concentrate (PCC) Drug Sales by Type (2021–2026)

4.1.2 Global Prothrombin Complex Concentrate (PCC) Drug Sales by Type (2027–2032)

4.1.3 Global Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Type (2021–2032)

4.2 Global Prothrombin Complex Concentrate (PCC) Drug Revenue by Type (2021–2032)

4.2.1 Global Prothrombin Complex Concentrate (PCC) Drug Revenue by Type (2021–2026)

4.2.2 Global Prothrombin Complex Concentrate (PCC) Drug Revenue by Type (2027–2032)

4.2.3 Global Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Type (2021–2032)

4.3 Global Prothrombin Complex Concentrate (PCC) Drug Price by Type (2021–2032)

5 Segment by Application

5.1 Global Prothrombin Complex Concentrate (PCC) Drug Sales by Application (2021–2032)

5.1.1 Global Prothrombin Complex Concentrate (PCC) Drug Sales by Application (2021–2026)

5.1.2 Global Prothrombin Complex Concentrate (PCC) Drug Sales by Application (2027–2032)

5.1.3 Global Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Application (2021–2032)

5.2 Global Prothrombin Complex Concentrate (PCC) Drug Revenue by Application (2021–2032)

5.2.1 Global Prothrombin Complex Concentrate (PCC) Drug Revenue by Application (2021–2026)

5.2.2 Global Prothrombin Complex Concentrate (PCC) Drug Revenue by Application (2027–2032)

5.2.3 Global Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Application (2021–2032)

5.3 Global Prothrombin Complex Concentrate (PCC) Drug Price by Application (2021–2032)

6 Key Companies Profiled

6.1 CSL Behring

6.1.1 CSL Behring Company Information

6.1.2 CSL Behring Description and Business Overview

6.1.3 CSL Behring Prothrombin Complex Concentrate (PCC) Drug Sales, Revenue, and Gross Margin (2021–2026)

6.1.4 CSL Behring Prothrombin Complex Concentrate (PCC) Drug Product Portfolio

6.1.5 CSL Behring Recent Developments/Updates

6.2 Grifols

6.2.1 Grifols Company Information

6.2.2 Grifols Description and Business Overview

6.2.3 Grifols Prothrombin Complex Concentrate (PCC) Drug Sales, Revenue, and Gross Margin (2021–2026)

6.2.4 Grifols Prothrombin Complex Concentrate (PCC) Drug Product Portfolio

6.2.5 Grifols Recent Developments/Updates

6.3 Octapharma

6.3.1 Octapharma Company Information

6.3.2 Octapharma Description and Business Overview

6.3.3 Octapharma Prothrombin Complex Concentrate (PCC) Drug Sales, Revenue, and Gross Margin (2021–2026)

6.3.4 Octapharma Prothrombin Complex Concentrate (PCC) Drug Product Portfolio

6.3.5 Octapharma Recent Developments/Updates

6.4 Prothya Biosolutions

6.4.1 Prothya Biosolutions Company Information

6.4.2 Prothya Biosolutions Description and Business Overview

6.4.3 Prothya Biosolutions Prothrombin Complex Concentrate (PCC) Drug Sales, Revenue, and Gross Margin (2021–2026)

6.4.4 Prothya Biosolutions Prothrombin Complex Concentrate (PCC) Drug Product Portfolio

6.4.5 Prothya Biosolutions Recent Developments/Updates

6.5 Takeda

6.5.1 Takeda Company Information

6.5.2 Takeda Description and Business Overview

6.5.3 Takeda Prothrombin Complex Concentrate (PCC) Drug Sales, Revenue, and Gross Margin (2021–2026)

6.5.4 Takeda Prothrombin Complex Concentrate (PCC) Drug Product Portfolio

6.5.5 Takeda Recent Developments/Updates

6.6 RAAS

6.6.1 RAAS Company Information

6.6.2 RAAS Description and Business Overview

6.6.3 RAAS Prothrombin Complex Concentrate (PCC) Drug Sales, Revenue, and Gross Margin (2021–2026)

6.6.4 RAAS Prothrombin Complex Concentrate (PCC) Drug Product Portfolio

6.6.5 RAAS Recent Developments/Updates

6.7 Hualan Bio

6.7.1 Hualan Bio Company Information

6.7.2 Hualan Bio Description and Business Overview

6.7.3 Hualan Bio Prothrombin Complex Concentrate (PCC) Drug Sales, Revenue, and Gross Margin (2021–2026)

6.7.4 Hualan Bio Prothrombin Complex Concentrate (PCC) Drug Product Portfolio

6.7.5 Hualan Bio Recent Developments/Updates

6.8 BOHUI

6.8.1 BOHUI Company Information

6.8.2 BOHUI Description and Business Overview

6.8.3 BOHUI Prothrombin Complex Concentrate (PCC) Drug Sales, Revenue, and Gross Margin (2021–2026)

6.8.4 BOHUI Prothrombin Complex Concentrate (PCC) Drug Product Portfolio

6.8.5 BOHUI Recent Developments/Updates

6.9 NUOYI BIO

6.9.1 NUOYI BIO Company Information

6.9.2 NUOYI BIO Description and Business Overview

6.9.3 NUOYI BIO Prothrombin Complex Concentrate (PCC) Drug Sales, Revenue, and Gross Margin (2021–2026)

6.9.4 NUOYI BIO Prothrombin Complex Concentrate (PCC) Drug Product Portfolio

6.9.5 NUOYI BIO Recent Developments/Updates

6.10 SINOPHARM

6.10.1 SINOPHARM Company Information

6.10.2 SINOPHARM Description and Business Overview

6.10.3 SINOPHARM Prothrombin Complex Concentrate (PCC) Drug Sales, Revenue, and Gross Margin (2021–2026)

6.10.4 SINOPHARM Prothrombin Complex Concentrate (PCC) Drug Product Portfolio

6.10.5 SINOPHARM Recent Developments/Updates

6.11 Guangdong Weilun

6.11.1 Guangdong Weilun Company Information

6.11.2 Guangdong Weilun Description and Business Overview

6.11.3 Guangdong Weilun Prothrombin Complex Concentrate (PCC) Drug Sales, Revenue, and Gross Margin (2021–2026)

6.11.4 Guangdong Weilun Prothrombin Complex Concentrate (PCC) Drug Product Portfolio

6.11.5 Guangdong Weilun Recent Developments/Updates

6.12 Weiguang Bio

6.12.1 Weiguang Bio Company Information

6.12.2 Weiguang Bio Description and Business Overview

6.12.3 Weiguang Bio Prothrombin Complex Concentrate (PCC) Drug Sales, Revenue, and Gross Margin (2021–2026)

6.12.4 Weiguang Bio Prothrombin Complex Concentrate (PCC) Drug Product Portfolio

6.12.5 Weiguang Bio Recent Developments/Updates

6.13 Kangbo Bio

6.13.1 Kangbo Bio Company Information

6.13.2 Kangbo Bio Description and Business Overview

6.13.3 Kangbo Bio Prothrombin Complex Concentrate (PCC) Drug Sales, Revenue, and Gross Margin (2021–2026)

6.13.4 Kangbo Bio Prothrombin Complex Concentrate (PCC) Drug Product Portfolio

6.13.5 Kangbo Bio Recent Developments/Updates

6.14 Huarun Boya

6.14.1 Huarun Boya Company Information

6.14.2 Huarun Boya Description and Business Overview

6.14.3 Huarun Boya Prothrombin Complex Concentrate (PCC) Drug Sales, Revenue, and Gross Margin (2021–2026)

6.14.4 Huarun Boya Prothrombin Complex Concentrate (PCC) Drug Product Portfolio

6.14.5 Huarun Boya Recent Developments/Updates

6.15 Taibang Biologic

6.15.1 Taibang Biologic Company Information

6.15.2 Taibang Biologic Description and Business Overview

6.15.3 Taibang Biologic Prothrombin Complex Concentrate (PCC) Drug Sales, Revenue, and Gross Margin (2021–2026)

6.15.4 Taibang Biologic Prothrombin Complex Concentrate (PCC) Drug Product Portfolio

6.15.5 Taibang Biologic Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Prothrombin Complex Concentrate (PCC) Drug Industry Chain Analysis

7.2 Prothrombin Complex Concentrate (PCC) Drug Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Prothrombin Complex Concentrate (PCC) Drug Production Mode & Process Analysis

7.4 Prothrombin Complex Concentrate (PCC) Drug Sales and Marketing

7.4.1 Prothrombin Complex Concentrate (PCC) Drug Sales Channels

7.4.2 Prothrombin Complex Concentrate (PCC) Drug Distributors

7.5 Prothrombin Complex Concentrate (PCC) Drug Customer Analysis

8 Prothrombin Complex Concentrate (PCC) Drug Market Dynamics

8.1 Prothrombin Complex Concentrate (PCC) Drug Industry Trends

8.2 Prothrombin Complex Concentrate (PCC) Drug Market Drivers

8.3 Prothrombin Complex Concentrate (PCC) Drug Market Challenges

8.4 Prothrombin Complex Concentrate (PCC) Drug Market Restraints

8.5 Impact of U.S. Tariffs

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Takeda

Octapharma AG

CSL Behring

Grifols S A

Prothya Biosolutions

List of Tables

Table 1. Global Prothrombin Complex Concentrate (PCC) Drug Market Value by Type (US$ Million), 2025 vs 2032

Table 2. Global Prothrombin Complex Concentrate (PCC) Drug Market Value by Usage Type (US$ Million), 2025 vs 2032

Table 3. Global Prothrombin Complex Concentrate (PCC) Drug Market Value by Manufacturing Process (US$ Million), 2025 vs 2032

Table 4. Global Prothrombin Complex Concentrate (PCC) Drug Market Value by Application (US$ Million), 2025 vs 2032

Table 5. Global Prothrombin Complex Concentrate (PCC) Drug Market Competitive Situation by Manufacturers in 2025

Table 6. Global Prothrombin Complex Concentrate (PCC) Drug Sales (K Units) of Key Manufacturers (2021–2026)

Table 7. Global Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Manufacturers (2021–2026)

Table 8. Global Prothrombin Complex Concentrate (PCC) Drug Revenue (US$ Million) by Manufacturers (2021–2026)

Table 9. Global Prothrombin Complex Concentrate (PCC) Drug Revenue Share by Manufacturers (2021–2026)

Table 10. Global Market Prothrombin Complex Concentrate (PCC) Drug Average Price (US$/Unit) of Key Manufacturers (2021–2026)

Table 11. Global Key Players of Prothrombin Complex Concentrate (PCC) Drug, Industry Ranking, 2023 vs 2024 vs 2025

Table 12. Global Key Manufacturers of Prothrombin Complex Concentrate (PCC) Drug, Manufacturing Sites and Headquarters

Table 13. Global Key Manufacturers of Prothrombin Complex Concentrate (PCC) Drug, Product Types and Applications

Table 14. Global Key Manufacturers of Prothrombin Complex Concentrate (PCC) Drug, Date of Entry into the Industry

Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 16. Global Prothrombin Complex Concentrate (PCC) Drug Companies by Tier (Tier 1, Tier 2, Tier 3), based on Prothrombin Complex Concentrate (PCC) Drug Revenue, 2025

Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 18. Global Prothrombin Complex Concentrate (PCC) Drug Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 19. Global Prothrombin Complex Concentrate (PCC) Drug Sales by Region (K Units), 2021–2026

Table 20. Global Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Region (2021–2026)

Table 21. Global Prothrombin Complex Concentrate (PCC) Drug Sales by Region (K Units), 2027–2032

Table 22. Global Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Region (2027–2032)

Table 23. Global Prothrombin Complex Concentrate (PCC) Drug Revenue by Region (US$ Million), 2021–2026

Table 24. Global Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Region (2021–2026)

Table 25. Global Prothrombin Complex Concentrate (PCC) Drug Revenue by Region (US$ Million), 2027–2032

Table 26. Global Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Region (2027–2032)

Table 27. North America Prothrombin Complex Concentrate (PCC) Drug Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 28. North America Prothrombin Complex Concentrate (PCC) Drug Sales by Country (K Units), 2021–2026

Table 29. North America Prothrombin Complex Concentrate (PCC) Drug Sales by Country (K Units), 2027–2032

Table 30. North America Prothrombin Complex Concentrate (PCC) Drug Revenue by Country (US$ Million), 2021–2026

Table 31. North America Prothrombin Complex Concentrate (PCC) Drug Revenue by Country (US$ Million), 2027–2032

Table 32. Europe Prothrombin Complex Concentrate (PCC) Drug Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 33. Europe Prothrombin Complex Concentrate (PCC) Drug Sales by Country (K Units), 2021–2026

Table 34. Europe Prothrombin Complex Concentrate (PCC) Drug Sales by Country (K Units), 2027–2032

Table 35. Europe Prothrombin Complex Concentrate (PCC) Drug Revenue by Country (US$ Million), 2021–2026

Table 36. Europe Prothrombin Complex Concentrate (PCC) Drug Revenue by Country (US$ Million), 2027–2032

Table 37. Asia Pacific Prothrombin Complex Concentrate (PCC) Drug Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)

Table 38. Asia Pacific Prothrombin Complex Concentrate (PCC) Drug Sales by Region (K Units), 2021–2026

Table 39. Asia Pacific Prothrombin Complex Concentrate (PCC) Drug Sales by Region (K Units), 2027–2032

Table 40. Asia Pacific Prothrombin Complex Concentrate (PCC) Drug Revenue by Region (US$ Million), 2021–2026

Table 41. Asia Pacific Prothrombin Complex Concentrate (PCC) Drug Revenue by Region (US$ Million), 2027–2032

Table 42. Latin America Prothrombin Complex Concentrate (PCC) Drug Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 43. Latin America Prothrombin Complex Concentrate (PCC) Drug Sales by Country (K Units), 2021–2026

Table 44. Latin America Prothrombin Complex Concentrate (PCC) Drug Sales by Country (K Units), 2027–2032

Table 45. Latin America Prothrombin Complex Concentrate (PCC) Drug Revenue by Country (US$ Million), 2021–2026

Table 46. Latin America Prothrombin Complex Concentrate (PCC) Drug Revenue by Country (US$ Million), 2027–2032

Table 47. Middle East and Africa Prothrombin Complex Concentrate (PCC) Drug Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 48. Middle East and Africa Prothrombin Complex Concentrate (PCC) Drug Sales by Country (K Units), 2021–2026

Table 49. Middle East and Africa Prothrombin Complex Concentrate (PCC) Drug Sales by Country (K Units), 2027–2032

Table 50. Middle East and Africa Prothrombin Complex Concentrate (PCC) Drug Revenue by Country (US$ Million), 2021–2026

Table 51. Middle East and Africa Prothrombin Complex Concentrate (PCC) Drug Revenue by Country (US$ Million), 2027–2032

Table 52. Global Prothrombin Complex Concentrate (PCC) Drug Sales (K Units) by Type (2021–2026)

Table 53. Global Prothrombin Complex Concentrate (PCC) Drug Sales (K Units) by Type (2027–2032)

Table 54. Global Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Type (2021–2026)

Table 55. Global Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Type (2027–2032)

Table 56. Global Prothrombin Complex Concentrate (PCC) Drug Revenue (US$ Million) by Type (2021–2026)

Table 57. Global Prothrombin Complex Concentrate (PCC) Drug Revenue (US$ Million) by Type (2027–2032)

Table 58. Global Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Type (2021–2026)

Table 59. Global Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Type (2027–2032)

Table 60. Global Prothrombin Complex Concentrate (PCC) Drug Price (US$/Unit) by Type (2021–2026)

Table 61. Global Prothrombin Complex Concentrate (PCC) Drug Price (US$/Unit) by Type (2027–2032)

Table 62. Global Prothrombin Complex Concentrate (PCC) Drug Sales (K Units) by Application (2021–2026)

Table 63. Global Prothrombin Complex Concentrate (PCC) Drug Sales (K Units) by Application (2027–2032)

Table 64. Global Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Application (2021–2026)

Table 65. Global Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Application (2027–2032)

Table 66. Global Prothrombin Complex Concentrate (PCC) Drug Revenue (US$ Million) by Application (2021–2026)

Table 67. Global Prothrombin Complex Concentrate (PCC) Drug Revenue (US$ Million) by Application (2027–2032)

Table 68. Global Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Application (2021–2026)

Table 69. Global Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Application (2027–2032)

Table 70. Global Prothrombin Complex Concentrate (PCC) Drug Price (US$/Unit) by Application (2021–2026)

Table 71. Global Prothrombin Complex Concentrate (PCC) Drug Price (US$/Unit) by Application (2027–2032)

Table 72. CSL Behring Company Information

Table 73. CSL Behring Description and Business Overview

Table 74. CSL Behring Prothrombin Complex Concentrate (PCC) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 75. CSL Behring Prothrombin Complex Concentrate (PCC) Drug Product

Table 76. CSL Behring Recent Developments/Updates

Table 77. Grifols Company Information

Table 78. Grifols Description and Business Overview

Table 79. Grifols Prothrombin Complex Concentrate (PCC) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 80. Grifols Prothrombin Complex Concentrate (PCC) Drug Product

Table 81. Grifols Recent Developments/Updates

Table 82. Octapharma Company Information

Table 83. Octapharma Description and Business Overview

Table 84. Octapharma Prothrombin Complex Concentrate (PCC) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 85. Octapharma Prothrombin Complex Concentrate (PCC) Drug Product

Table 86. Octapharma Recent Developments/Updates

Table 87. Prothya Biosolutions Company Information

Table 88. Prothya Biosolutions Description and Business Overview

Table 89. Prothya Biosolutions Prothrombin Complex Concentrate (PCC) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 90. Prothya Biosolutions Prothrombin Complex Concentrate (PCC) Drug Product

Table 91. Prothya Biosolutions Recent Developments/Updates

Table 92. Takeda Company Information

Table 93. Takeda Description and Business Overview

Table 94. Takeda Prothrombin Complex Concentrate (PCC) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 95. Takeda Prothrombin Complex Concentrate (PCC) Drug Product

Table 96. Takeda Recent Developments/Updates

Table 97. RAAS Company Information

Table 98. RAAS Description and Business Overview

Table 99. RAAS Prothrombin Complex Concentrate (PCC) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 100. RAAS Prothrombin Complex Concentrate (PCC) Drug Product

Table 101. RAAS Recent Developments/Updates

Table 102. Hualan Bio Company Information

Table 103. Hualan Bio Description and Business Overview

Table 104. Hualan Bio Prothrombin Complex Concentrate (PCC) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 105. Hualan Bio Prothrombin Complex Concentrate (PCC) Drug Product

Table 106. Hualan Bio Recent Developments/Updates

Table 107. BOHUI Company Information

Table 108. BOHUI Description and Business Overview

Table 109. BOHUI Prothrombin Complex Concentrate (PCC) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 110. BOHUI Prothrombin Complex Concentrate (PCC) Drug Product

Table 111. BOHUI Recent Developments/Updates

Table 112. NUOYI BIO Company Information

Table 113. NUOYI BIO Description and Business Overview

Table 114. NUOYI BIO Prothrombin Complex Concentrate (PCC) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 115. NUOYI BIO Prothrombin Complex Concentrate (PCC) Drug Product

Table 116. NUOYI BIO Recent Developments/Updates

Table 117. SINOPHARM Company Information

Table 118. SINOPHARM Description and Business Overview

Table 119. SINOPHARM Prothrombin Complex Concentrate (PCC) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 120. SINOPHARM Prothrombin Complex Concentrate (PCC) Drug Product

Table 121. SINOPHARM Recent Developments/Updates

Table 122. Guangdong Weilun Company Information

Table 123. Guangdong Weilun Description and Business Overview

Table 124. Guangdong Weilun Prothrombin Complex Concentrate (PCC) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 125. Guangdong Weilun Prothrombin Complex Concentrate (PCC) Drug Product

Table 126. Guangdong Weilun Recent Developments/Updates

Table 127. Weiguang Bio Company Information

Table 128. Weiguang Bio Description and Business Overview

Table 129. Weiguang Bio Prothrombin Complex Concentrate (PCC) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 130. Weiguang Bio Prothrombin Complex Concentrate (PCC) Drug Product

Table 131. Weiguang Bio Recent Developments/Updates

Table 132. Kangbo Bio Company Information

Table 133. Kangbo Bio Description and Business Overview

Table 134. Kangbo Bio Prothrombin Complex Concentrate (PCC) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 135. Kangbo Bio Prothrombin Complex Concentrate (PCC) Drug Product

Table 136. Kangbo Bio Recent Developments/Updates

Table 137. Huarun Boya Company Information

Table 138. Huarun Boya Description and Business Overview

Table 139. Huarun Boya Prothrombin Complex Concentrate (PCC) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 140. Huarun Boya Prothrombin Complex Concentrate (PCC) Drug Product

Table 141. Huarun Boya Recent Developments/Updates

Table 142. Taibang Biologic Company Information

Table 143. Taibang Biologic Description and Business Overview

Table 144. Taibang Biologic Prothrombin Complex Concentrate (PCC) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 145. Taibang Biologic Prothrombin Complex Concentrate (PCC) Drug Product

Table 146. Taibang Biologic Recent Developments/Updates

Table 147. Key Raw Materials Lists

Table 148. Raw Materials Key Suppliers Lists

Table 149. Prothrombin Complex Concentrate (PCC) Drug Distributors List

Table 150. Prothrombin Complex Concentrate (PCC) Drug Customers List

Table 151. Prothrombin Complex Concentrate (PCC) Drug Market Trends

Table 152. Prothrombin Complex Concentrate (PCC) Drug Market Drivers

Table 153. Prothrombin Complex Concentrate (PCC) Drug Market Challenges

Table 154. Prothrombin Complex Concentrate (PCC) Drug Market Restraints

Table 155. Research Programs/Design for This Report

Table 156. Key Data Information from Secondary Sources

Table 157. Key Data Information from Primary Sources

Table 158. Authors List of This Report

List of Figures

Figure 1. Product Picture of Prothrombin Complex Concentrate (PCC) Drug

Figure 2. Global Prothrombin Complex Concentrate (PCC) Drug Market Value by Type (US$ Million), 2021–2032

Figure 3. Global Prothrombin Complex Concentrate (PCC) Drug Market Share by Type: 2025 & 2032

Figure 4. Beriplex Product Picture

Figure 5. Profilnine Product Picture

Figure 6. Octaplex Product Picture

Figure 7. Prothromplex Product Picture

Figure 8. Cofact Product Picture

Figure 9. Other Product Picture

Figure 10. Global Prothrombin Complex Concentrate (PCC) Drug Market Value by Usage Type (US$ Million), 2021–2032

Figure 11. Global Prothrombin Complex Concentrate (PCC) Drug Market Share by Usage Type: 2025 vs 2032

Figure 12. Lyophilized Powder Form Product Picture

Figure 13. Liquid Injection Form Product Picture

Figure 14. Global Prothrombin Complex Concentrate (PCC) Drug Market Value by Manufacturing Process (US$ Million), 2021–2032

Figure 15. Global Prothrombin Complex Concentrate (PCC) Drug Market Share by Manufacturing Process: 2025 vs 2032

Figure 16. Plasma-Derived Product Picture

Figure 17. Recombinant Bioengineered Product Picture

Figure 18. Global Prothrombin Complex Concentrate (PCC) Drug Market Value by Application (US$ Million), 2021–2032

Figure 19. Global Prothrombin Complex Concentrate (PCC) Drug Market Share by Application: 2025 & 2032

Figure 20. Hemophilia B

Figure 21. Acquired Coagulation Factor Deficiency

Figure 22. Global Prothrombin Complex Concentrate (PCC) Drug Revenue, (US$ Million), 2021 vs 2025 vs 2032

Figure 23. Global Prothrombin Complex Concentrate (PCC) Drug Market Size (US$ Million), 2021–2032

Figure 24. Global Prothrombin Complex Concentrate (PCC) Drug Sales (K Units), 2021–2032

Figure 25. Global Prothrombin Complex Concentrate (PCC) Drug Average Price (US$/Unit), 2021–2032

Figure 26. Prothrombin Complex Concentrate (PCC) Drug Report Years Considered

Figure 27. Prothrombin Complex Concentrate (PCC) Drug Sales Share by Manufacturers in 2025

Figure 28. Global Prothrombin Complex Concentrate (PCC) Drug Revenue Share by Manufacturers in 2025

Figure 29. Top 5 and Top 10 Global Prothrombin Complex Concentrate (PCC) Drug Players: Market Share by Revenue in Prothrombin Complex Concentrate (PCC) Drug in 2025

Figure 30. Prothrombin Complex Concentrate (PCC) Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

Figure 31. Global Prothrombin Complex Concentrate (PCC) Drug Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Figure 32. North America Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Country (2021–2032)

Figure 33. North America Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Country (2021–2032)

Figure 34. United States Prothrombin Complex Concentrate (PCC) Drug Revenue Growth Rate (US$ Million), 2021–2032

Figure 35. Canada Prothrombin Complex Concentrate (PCC) Drug Revenue Growth Rate (US$ Million), 2021–2032

Figure 36. Europe Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Country (2021–2032)

Figure 37. Europe Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Country (2021–2032)

Figure 38. Germany Prothrombin Complex Concentrate (PCC) Drug Revenue Growth Rate (US$ Million), 2021–2032

Figure 39. France Prothrombin Complex Concentrate (PCC) Drug Revenue Growth Rate (US$ Million), 2021–2032

Figure 40. U.K. Prothrombin Complex Concentrate (PCC) Drug Revenue Growth Rate (US$ Million), 2021–2032

Figure 41. Italy Prothrombin Complex Concentrate (PCC) Drug Revenue Growth Rate (US$ Million), 2021–2032

Figure 42. Russia Prothrombin Complex Concentrate (PCC) Drug Revenue Growth Rate (US$ Million), 2021–2032

Figure 43. Asia Pacific Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Region (2021–2032)

Figure 44. Asia Pacific Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Region (2021–2032)

Figure 45. China Prothrombin Complex Concentrate (PCC) Drug Revenue Growth Rate (US$ Million), 2021–2032

Figure 46. Japan Prothrombin Complex Concentrate (PCC) Drug Revenue Growth Rate (US$ Million), 2021–2032

Figure 47. South Korea Prothrombin Complex Concentrate (PCC) Drug Revenue Growth Rate (US$ Million), 2021–2032

Figure 48. India Prothrombin Complex Concentrate (PCC) Drug Revenue Growth Rate (US$ Million), 2021–2032

Figure 49. Australia Prothrombin Complex Concentrate (PCC) Drug Revenue Growth Rate (US$ Million), 2021–2032

Figure 50. China Taiwan Prothrombin Complex Concentrate (PCC) Drug Revenue Growth Rate (US$ Million), 2021–2032

Figure 51. Southeast Asia Prothrombin Complex Concentrate (PCC) Drug Revenue Growth Rate (US$ Million), 2021–2032

Figure 52. Latin America Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Country (2021–2032)

Figure 53. Latin America Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Country (2021–2032)

Figure 54. Mexico Prothrombin Complex Concentrate (PCC) Drug Revenue Growth Rate (US$ Million), 2021–2032

Figure 55. Brazil Prothrombin Complex Concentrate (PCC) Drug Revenue Growth Rate (US$ Million), 2021–2032

Figure 56. Argentina Prothrombin Complex Concentrate (PCC) Drug Revenue Growth Rate (US$ Million), 2021–2032

Figure 57. Middle East and Africa Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Country (2021–2032)

Figure 58. Middle East and Africa Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Country (2021–2032)

Figure 59. Turkey Prothrombin Complex Concentrate (PCC) Drug Revenue Growth Rate (US$ Million), 2021–2032

Figure 60. Saudi Arabia Prothrombin Complex Concentrate (PCC) Drug Revenue Growth Rate (US$ Million), 2021–2032

Figure 61. UAE Prothrombin Complex Concentrate (PCC) Drug Revenue Growth Rate (US$ Million), 2021–2032

Figure 62. Global Sales Market Share of Prothrombin Complex Concentrate (PCC) Drug by Type (2021–2032)

Figure 63. Global Revenue Market Share of Prothrombin Complex Concentrate (PCC) Drug by Type (2021–2032)

Figure 64. Global Prothrombin Complex Concentrate (PCC) Drug Price (US$/Unit) by Type (2021–2032)

Figure 65. Global Sales Market Share of Prothrombin Complex Concentrate (PCC) Drug by Application (2021–2032)

Figure 66. Global Revenue Market Share of Prothrombin Complex Concentrate (PCC) Drug by Application (2021–2032)

Figure 67. Global Prothrombin Complex Concentrate (PCC) Drug Price (US$/Unit) by Application (2021–2032)

Figure 68. Prothrombin Complex Concentrate (PCC) Drug Value Chain

Figure 69. Channels of Distribution (Direct Vs Distribution)

Figure 70. Bottom-up and Top-down Approaches for This Report

Figure 71. Data Triangulation

Figure 72. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Human Prothrombin Complex Concentrate Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Human Prothrombin Complex Market Research Report 2025

Global Precipitated Calcium Carbonate PCC for Adhesives Sealants Market Research Report 2025

Global Anticoagulant Citrate Phosphate Dextrose Solution CPD Market Research Report 2025

Global Coagulation Factor Concentrates Market Research Report 2024

Global Carboplatin Market Research Report 2025

Factor IX Complex Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

4 Factor Pro thrombin Complex Concentrate Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Prothrombin Complex Concentrate PCC Market Research Report 2024

Global Ultra fine Precipitated Calcium Carbonate PCC Market Research Report 2025

Global Activated Prothrombin Complex Concentrate aPCC Market Research Report 2024

Global Activated Partial Thromboplastin Market Research Report 2024

Prothrombin Time Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Activated Protein C Market Research Report 2025

Global Point of Care POC Coagulation Analyzer Market Research Report 2025

Global Coagulation POC Analyzer Market Research Report 2025

Global POC Coagulation Analyzer Market Research Report 2025

Global PCT Chamber Market Research Report 2024

Global Thrombin Preparation Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions